(redirected from Inducible Nitric Oxide Synthase)
Also found in: Medical.
iNOSInducible Nitric Oxide Synthase (aka Inducible Isoform of Nitric Oxide Synthase)
iNOSImproved Neds Operating System
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
Disruption of inducible nitric oxide synthase improves beta-adrenergic inotropic responsiveness but not the survival of mice with cytokine-induced cardiomyopathy.
Inducible nitric oxide synthase mRNA expression level was significantly higher in the vehicle group rats than in the sham group, IFX treatment significantly reduced iNOS mRNA expression on day 7 and 14 as compared to the vehicle group (Figure 4) (p < 0.05).
Raviten, an injectable solution of S-ethylisothiouronium diethylphosphate, has been shown in preclinical and exploratory clinical trials to inhibit inducible nitric oxide synthase (NOS), endothelial NOS, and neuronal NOS, thereby controlling overproduction of nitric oxide; and to normalize low blood pressure in patients suffering from intradialytic hypotension, as well as other low blood pressure conditions.
Estrogen regulation of nitric oxide and inducible nitric oxide synthase (iNOS) in immune cells: Implications for immunity, autoimmune diseases, and apoptosis.
iNOS: inducible nitric oxide synthase; eNOS: endothelial nitric oxide synthase
During 24 hours after onset of ischemic stroke, nitric oxide (NO) is mainly produced by activation of both inducible nitric oxide synthase (iNOS) and neuronal nitric oxide synthase (nNOS).
Inflammation, immunoregulation, and inducible nitric oxide synthase. J Leukoc Biol.
Higher doses of vitamin [D.sub.3] also produced significant decreases in skin levels of tumor necrosis factor-alpha (TNF-alpha) (P = .02) and inducible nitric oxide synthase (iNOS) (P = .04) compared with placebo, reported Dr.
Barbul, "Supplemental dietary arginine enhances wound healing in normal but not inducible nitric oxide synthase knockout mice," Surgery, vol.
Previous works indicated that inducible nitric oxide synthase (iNOS) is expressed by several human gastrointestinal neoplasms including gastric cancer [61], colonic adenomas [62], Barrett's esophagus, and associated adenocarcinomas [63].